Paul J. Tacken

4.0k total citations · 1 hit paper
41 papers, 3.2k citations indexed

About

Paul J. Tacken is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Paul J. Tacken has authored 41 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 21 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Paul J. Tacken's work include Immunotherapy and Immune Responses (28 papers), T-cell and B-cell Immunology (17 papers) and RNA Interference and Gene Delivery (13 papers). Paul J. Tacken is often cited by papers focused on Immunotherapy and Immune Responses (28 papers), T-cell and B-cell Immunology (17 papers) and RNA Interference and Gene Delivery (13 papers). Paul J. Tacken collaborates with scholars based in Netherlands, United States and Spain. Paul J. Tacken's co-authors include Carl G. Figdor, Ruurd Torensma, I. Jolanda M. de Vries, Luis J. Cruz, Remco Fokkink, Gosse J. Adema, Ben Joosten, Cornelis J.A. Punt, Martin Kreutz and Louis M. Havekes and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Nature reviews. Immunology.

In The Last Decade

Paul J. Tacken

41 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting

2007 615 citations Paul J. Tacken, I. Jolanda M. de Vries et al. Nature reviews. Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul J. Tacken Netherlands	24	2.4k	1.4k	555	292	250	41	3.2k
Takashi Nakamura Japan	32	1.5k 0.6×	1.8k 1.3×	532 1.0×	553 1.9×	157 0.6×	117	3.3k
Juliana Idoyaga United States	33	3.8k 1.6×	1.2k 0.9×	734 1.3×	138 0.5×	363 1.5×	65	4.8k
Patricia L. Mottram Australia	27	1.9k 0.8×	1.1k 0.8×	210 0.4×	196 0.7×	291 1.2×	74	3.2k
Sven Burgdorf Germany	25	2.3k 1.0×	1.3k 0.9×	390 0.7×	114 0.4×	321 1.3×	42	3.6k
Jaap Oostendorp Netherlands	20	2.2k 1.0×	1.0k 0.8×	1.2k 2.2×	163 0.6×	732 2.9×	36	3.1k
Anne Sundblad Sweden	20	1.1k 0.5×	713 0.5×	160 0.3×	185 0.6×	145 0.6×	31	1.9k
Eli Kedar Israel	30	1.6k 0.7×	715 0.5×	456 0.8×	110 0.4×	403 1.6×	117	2.5k
Marek Kovář Czechia	27	1.5k 0.6×	590 0.4×	745 1.3×	377 1.3×	163 0.7×	64	2.7k
David A. Zaharoff United States	25	846 0.4×	735 0.5×	450 0.8×	481 1.6×	127 0.5×	66	2.2k
Sue D. Xiang Australia	21	1.0k 0.4×	802 0.6×	162 0.3×	197 0.7×	187 0.7×	44	1.8k

Countries citing papers authored by Paul J. Tacken

Since Specialization

Citations

This map shows the geographic impact of Paul J. Tacken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul J. Tacken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul J. Tacken more than expected).

Fields of papers citing papers by Paul J. Tacken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul J. Tacken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul J. Tacken. The network helps show where Paul J. Tacken may publish in the future.

Co-authorship network of co-authors of Paul J. Tacken

This figure shows the co-authorship network connecting the top 25 collaborators of Paul J. Tacken. A scholar is included among the top collaborators of Paul J. Tacken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul J. Tacken. Paul J. Tacken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cruz, Luis J., Paul J. Tacken, Félix Rueda, et al.. (2012). Targeting Nanoparticles to Dendritic Cells for Immunotherapy. Methods in enzymology on CD-ROM/Methods in enzymology. 509. 143–163. 107 indexed citations

Schreibelt, Gerty, Lieke J.J. Klinkenberg, Luis J. Cruz, et al.. (2012). The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells. Blood. 119(10). 2284–2292. 191 indexed citations

Aarntzen, Erik H.J.G., I. Jolanda M. de Vries, J Goertz, et al.. (2012). Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters. Cancer Immunology Immunotherapy. 61(11). 2003–2011. 19 indexed citations

Cruz, Luis J., Paul J. Tacken, Remco Fokkink, & Carl G. Figdor. (2011). The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells. Biomaterials. 32(28). 6791–6803. 164 indexed citations

Tacken, Paul J. & Carl G. Figdor. (2011). Targeted antigen delivery and activation of dendritic cells in vivo: Steps towards cost effective vaccines. Seminars in Immunology. 23(1). 12–20. 103 indexed citations

Tel, Jurjen, Daniel Benítez‐Ribas, Alessandra Cambi, et al.. (2011). DEC‐205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cells. European Journal of Immunology. 41(4). 1014–1023. 59 indexed citations

Tacken, Paul J., Ingrid S. Zeelenberg, Luis J. Cruz, et al.. (2011). Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity. Blood. 118(26). 6836–6844. 147 indexed citations

Cruz, Luis J., Paul J. Tacken, Remco Fokkink, et al.. (2010). Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro. Journal of Controlled Release. 144(2). 118–126. 233 indexed citations

Benítez‐Ribas, Daniel, Paul J. Tacken, Cornelis J.A. Punt, I. Jolanda M. de Vries, & Carl G. Figdor. (2008). Activation of Human Plasmacytoid Dendritic Cells by TLR9 Impairs FcγRII-Mediated Uptake of Immune Complexes and Presentation by MHC Class II. The Journal of Immunology. 181(8). 5219–5224. 23 indexed citations

10.

Tacken, Paul J., Ben Joosten, Anita Reddy, et al.. (2008). No Advantage of Cell-Penetrating Peptides over Receptor-Specific Antibodies in Targeting Antigen to Human Dendritic Cells for Cross-Presentation. The Journal of Immunology. 180(11). 7687–7696. 34 indexed citations

11.

Tacken, Paul J., I. Jolanda M. de Vries, Ruurd Torensma, & Carl G. Figdor. (2007). Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nature reviews. Immunology. 7(10). 790–802. 615 indexed citations breakdown →

12.

Dakappagari, Naveen, Toshiaki Maruyama, Mark W. Renshaw, et al.. (2006). Internalizing Antibodies to the C-Type Lectins, L-SIGN and DC-SIGN, Inhibit Viral Glycoprotein Binding and Deliver Antigen to Human Dendritic Cells for the Induction of T Cell Responses. The Journal of Immunology. 176(1). 426–440. 39 indexed citations

13.

Tacken, Paul J. & Joseph J. Batenburg. (2006). Monocyte CD64 or CD89 targeting by surfactant protein D/anti‐Fc receptor mediates bacterial uptake. Immunology. 117(4). 494–501. 5 indexed citations

14.

Tacken, Paul J., Ruurd Torensma, & Carl G. Figdor. (2006). Targeting antigens to dendritic cells in vivo. Immunobiology. 211(6-8). 599–608. 92 indexed citations

15.

Tacken, Paul J., I. Jolanda M. de Vries, Karlijn Gijzen, et al.. (2005). Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti–DC-SIGN antibody. Blood. 106(4). 1278–1285. 219 indexed citations

16.

Tacken, Paul J., Kevan L. Hartshorn, Mitchell R. White, et al.. (2004). Effective Targeting of Pathogens to Neutrophils via Chimeric Surfactant Protein D/Anti-CD89 Protein. The Journal of Immunology. 172(8). 4934–4940. 18 indexed citations

17.

Goudriaan, Jeltje R., Paul J. Tacken, Vivian E.H. Dahlmans, et al.. (2001). Protection From Obesity in Mice Lacking the VLDL Receptor. Arteriosclerosis Thrombosis and Vascular Biology. 21(9). 1488–1493. 107 indexed citations

18.

Tacken, Paul J., Marten H. Hofker, Louis M. Havekes, & Ko Willems van Dijk. (2001). Living up to a name: the role of the VLDL receptor in lipid metabolism. Current Opinion in Lipidology. 12(3). 275–279. 59 indexed citations

19.

Tacken, Paul J., et al.. (2000). Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E. Biochemical Journal. 347(2). 357–361. 13 indexed citations

20.

Schuur, A. Gerlienke, Paul J. Tacken, Theo J. Visser, & Abraham Brouwer. (1998). Modulating effects of thyroid state on the induction of biotransformation enzymes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Environmental Toxicology and Pharmacology. 5(1). 7–16. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact